Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms

被引:74
作者
Backes, Christian S. [1 ]
Friedmann, Kim S. [1 ]
Mang, Sebastian [1 ]
Knoerck, Arne [1 ]
Hoth, Markus [1 ]
Kummerow, Carsten [1 ]
机构
[1] Univ Saarland, Sch Med, Dept Biophys, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany
关键词
natural killer cells (NK cells); cancer; apoptosis; necrosis (necrotic death); cell death; calcium; caspase; cellular immune response; imaging; immunology; CYTOTOXIC T-LYMPHOCYTES; CALCIUM INFLUX; PERFORIN; THERAPY; IMMUNOTHERAPY; EXOCYTOSIS; EXPRESSION; GRANULES; SYNAPSE; LIGHT;
D O I
10.1074/jbc.RA118.004549
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immune therapy of cancer is among the most promising recent advances in medicine. Whether the immune system can keep cancer in check depends on, among other factors, the efficiency of immune cells to recognize and eliminate cancer cells. We describe a time-resolved single-cell assay that reports the quality, quantity, and kinetics of target cell death induced by single primary human natural killer (NK) cells. The assay reveals that single NK cells induce cancer cell death by apoptosis and necrosis but also by mixed forms. Inhibition of either one of the two major cytotoxic pathways, perforin/granzyme release or FasL/FasR interaction, unmasked the parallel activity of the other one. Ca2+ influx through Orai channels is important for tuning killer cell function. We found that the apoptosis/necrosis ratio of cancer cell death by NK cells is controlled by the magnitude of Ca2+ entry and furthermore by the relative concentrations of perforin and granzyme B. The possibility to change the apoptosis/necrosis ratio employed by NK cells offers an intriguing possibility to modulate the immunogenicity of the tumor microenvironment.
引用
收藏
页码:16348 / 16363
页数:16
相关论文
共 47 条
  • [1] Evaluation of recombinant caspase specificity by competitive substrates
    Benkova, Bistra
    Lozanov, Valentin
    Ivanov, Ivaylo P.
    Mitev, Vanio
    [J]. ANALYTICAL BIOCHEMISTRY, 2009, 394 (01) : 68 - 74
  • [2] Syntaxin 8 is required for efficient lytic granule trafficking in cytotoxic T lymphocytes
    Bhat, Shruthi S.
    Friedmann, Kim S.
    Knoerck, Arne
    Hoxha, Cora
    Leidinger, Petra
    Backes, Christina
    Meese, Eckart
    Keller, Andreas
    Rettig, Jens
    Hoth, Markus
    Qu, Bin
    Schwarz, Eva C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1653 - 1664
  • [3] Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned
    Boudreau, Jeanette E.
    Hsu, Katharine C.
    [J]. TRENDS IN IMMUNOLOGY, 2018, 39 (03) : 222 - 239
  • [4] Caricchio R, 1998, J IMMUNOL, V161, P241
  • [5] Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer
    Chia, Jenny
    Yeo, Kim Pin
    Whisstock, James C.
    Dunstone, Michelle A.
    Trapani, Joseph A.
    Voskoboinik, Ilia
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (24) : 9809 - 9814
  • [6] Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells
    Clausen, J
    Vergeiner, B
    Enk, M
    Petzer, AL
    Gastl, G
    Gunsilius, E
    [J]. IMMUNOBIOLOGY, 2003, 207 (02) : 85 - 93
  • [7] Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules
    de Saint Basile, Genevieve
    Menasche, Gael
    Fischer, Alain
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (08) : 568 - 579
  • [8] Frey M, 1998, J IMMUNOL, V161, P400
  • [9] Rituximab in the treatment of non-Hodgkin's lymphoma - a critical evaluation of randomized controlled trials
    Griffin, Morag Meriel
    Morley, Nick
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 803 - 811
  • [10] Targeting natural killer cells in cancer immunotherapy
    Guillerey, Camille
    Huntington, Nicholas D.
    Smyth, Mark J.
    [J]. NATURE IMMUNOLOGY, 2016, 17 (09) : 1025 - 1036